PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21529379-5	2011	RESULTS: The combination therapy of AQ and SP results in more pronounced hepatotoxicity as revealed by elevated level of serum ALT, AST with respect to their individual drug exposure regimen.	Amodiaquine	36-38	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	132-135	
17222819-3	2007	Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).	Amodiaquine	18-29	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	168-194	
17222819-3	2007	Pretreatment with amodiaquine also improved the survival rate of the hepatitis mice, and this improvement was partially associated with the decrease in serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT).	Amodiaquine	18-29	solute carrier family 17 (anion/sugar transporter), member 5	Mus musculus	196-199